checkAd
    Startseite > Aktien > Akero Therapeutics > Nachrichten
    Akero Therapeutics Aktie
    17,935
     
    EUR
    +6,12 %
    +1,035 EUR
    Letzter Kurs 28.05.24 Tradegate
    17,545
     
    EUR
    570 STK
    Geldkurs 18:13:45
    17,655
     
    EUR
    570 STK
    Briefkurs 18:13:45
    ISIN: US00973Y1082 · WKN: A2PLNP · SYM: 0K4 · USA

    Neueste Nachrichten

    Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
    13:00 Uhr · globenewswire · Akero Therapeutics
    AKRO EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO
    22.05.24 · Business Wire (engl.) · Akero Therapeutics
    Kirby McInerney LLP Reminds Akero Therapeutics, Inc. (AKRO) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    14.05.24 · Business Wire (engl.) · Akero Therapeutics
    AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
    11.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    10.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    10.05.24 · globenewswire · Akero Therapeutics
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    09.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    08.05.24 · globenewswire · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    07.05.24 · Business Wire (engl.) · Akero Therapeutics
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors
    03.05.24 · Business Wire (engl.) · Akero Therapeutics